Mahon Paul A
MAHON PAUL A, EVP, GC, reported a transaction classified as exercise at UNITED THERAPEUTICS Corp involving 8300.000000 shares for an estimated $0.00. Reported holdings after the transaction were 30940.000000 shares. The stored filing text includes a detected 10b5-1 reference.
- Trade date
- Oct 15, 2026
- Filing date
- Oct 16, 2026
How reported position traded is calculated
Not calculated for derivative securities.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
UTHR price since this filing
Daily closing prices, with the filing date and available return windowsTransaction facts
Stored Form 4 columns with their raw values
- Type
- exercise Code M
- Identifier
- 0001231589-26-000022 Stock Option
- Transaction date
- Oct 15, 2026 Filed Oct 16, 2026, 08:34 PM · 1d delay
- Shares
- 8,300 sh $0.00 per share
- Estimated value
- $0 Computed from shares × price
- Holdings after
- 30,940 sh Direct
Filing signal explanations
Badges describe filing facts only — not predictions.
-16 points
Compact filing score computed from stored Form 4 facts. Version v1.
This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.
How this score is calculated
- direct_ownership+6 points
direct_or_indirect_ownership = D
Direct ownership reports the insider's personal stake. - timely_filing+4 points
reporting_delay_days = 1
Filing reported within two business days of the transaction. - derivative_transaction-16 points
is_derivative = true
Derivative exercise rows are less discretionary than open-market purchases. - tenb5_1_detected-10 points
is_10b5_1 = true
Stored filing content includes detected 10b5-1 language.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
EVP & GENERAL COUNSEL
- F1
This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025.
- F2
This transaction was executed in multiple trades at prices ranging from $541.015 to $541.97. The price reported above reflects the weighted average price. The reporting person hereby undertakes to pro…
- F3
This transaction was executed in multiple trades at prices ranging from $542.035 to $542.98. The price reported above reflects the weighted average price. The reporting person hereby undertakes to pro…
- F4
This transaction was executed in multiple trades at prices ranging from $543.155 to $544.07. The price reported above reflects the weighted average price. The reporting person hereby undertakes to pro…
- F5
This transaction was executed in multiple trades at prices ranging from $544.22 to $545.17. The price reported above reflects the weighted average price. The reporting person hereby undertakes to prov…
- F6
This transaction was executed in multiple trades at prices ranging from $545.23 to $546.22. The price reported above reflects the weighted average price. The reporting person hereby undertakes to prov…
- F7
This transaction was executed in multiple trades at prices ranging from $546.27 to $547.06. The price reported above reflects the weighted average price. The reporting person hereby undertakes to prov…
0 other transactions
0 recent txs